Topical tacrolimus is effective for facial lesions of psoriasis [4]

Acta Dermato-Venereologica

Volumn 80, Issue 6, 2000, Pages 451-

  Yamamoto, T ^a   Nishioka, K ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TACALCITOL; TACROLIMUS;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; PRIORITY JOURNAL; PSORIASIS; REMISSION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; FACIAL DERMATOSES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT OUTCOME;

EID: 0034486540     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. FK-506, a novel immunosuppressam isolated from a streptomyces. II: Immunosuppressive effect of FK-506 in vitro
2. The mechanism of action of cyclosporin A and FK 506
3. Topical tacrolimus is not effective in chronic plaque psoriasis
4. Tacrolimus ointment improves psoriasis in a microplaque assay